New Drug Brings Hope for Alzheimer's Disease Patients

Former President Ronald Reagan is one of the estimated four million Americans who have been diagnosed with Alzheimer's Disease. For years, many drugs have been available to Alzheimer's patients offering them short-term treatments, but now a new liquid drug may bring more hope to those suffering from the disease. According to researchers, an experimental drug called Neotrofin may be the world's first Alzheimer's disease therapy drug that regenerates nerve cells in the brain, potentially bringing patients long-term effects.

To date, Neotrofin has been safely tested on 1,500 people and has had positive results. Two recent studies support the belief that Neotrofin may indeed be helping Alzheimer's patients. Brain scans from patients who participated in a recent clinical study demonstrate that Neotrofin promotes brain activity in patients, leading to significant improvements in memory and judgement. In addition, at a recent medical conference in London, it was announced that Neotrofin significantly increased the number of stem cells in the brains of adult mice.

NeoTherapeutics, Inc., the California based drug company that is developing Neotrofin, is launching a new clinical trial for Alzheimer's disease this April. The new study will be held in many major metropolitan areas around the country.

For more information on participating in the clinical trials of Neotrofin please contact, 949-788-6700 ext. 300 or visit the Neotrofin website.

Go To Page: 1

Articles in this Topic    Discussions in this Topic